Screening for Pancreatic Exocrine Insufficieny in Metabolic Associated Fatty Liver Disease Patients (NCT05804409) | Clinical Trial Compass
UnknownNot Applicable
Screening for Pancreatic Exocrine Insufficieny in Metabolic Associated Fatty Liver Disease Patients
70 participantsStarted 2023-06
Plain-language summary
to investigate the frequency of PEI in MAFLD
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age greater than 18 years, Patients diagnosed as MAFLD
Exclusion Criteria:
* Patients use steatogenic medications, hormone replacement therapy or herbal products, any alcohol intake.
* Patients with any history of pancreatic diseases like acute pancreatitis, chronic pancreatitis and pancreatic surgery.
* Patients with any malignancy.